JEFFREY WHITE: Open Payments
NPI 1033559174 · DELHI, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,373 in 134 payments from 15 companies in 2025. Trend: 2023 $1,466 · 2024 $1,582 · 2025 $2,373
Food & beverage: $2,271Education: $103
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $300 |
| Vanda Pharmaceuticals Inc. | 11 | $261 |
| Lundbeck LLC | 12 | $217 |
| ABBVIE INC. | 11 | $179 |
| Axsome Therapeutics, Inc. | 14 | $175 |
| E.R. Squibb & Sons, L.L.C. | 13 | $175 |
| Otsuka America Pharmaceutical, Inc. | 11 | $156 |
| Indivior Inc. | 9 | $155 |
| Supernus Pharmaceuticals, Inc. | 5 | $145 |
| Janssen Pharmaceuticals, Inc | 7 | $133 |
Products named: ARISTADA, REXULTI, FANAPT, VRAYLAR, Auvelity, COBENFY, SUBLOCADE, Qelbree.
Industry payments across LA — which companies pay providers there.
